SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-046546
Filing Date
2019-12-20
Accepted
2019-12-20 16:05:54
Documents
12
Period of Report
2019-12-20
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_TERM B LOAN reta-8k_20191220.htm   iXBRL 8-K 40023
  Complete submission text file 0001564590-19-046546.txt   171559

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA reta-20191220.xsd EX-101.SCH 5964
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20191220_lab.xml EX-101.LAB 19457
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20191220_pre.xml EX-101.PRE 11624
7 EXTRACTED XBRL INSTANCE DOCUMENT reta-8k_20191220_htm.xml XML 3555
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 191301343
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences